Financial statements Best-Life Biotechnology

Balance sheet of Best-Life Biotechnology

Company age:

Age:

15 y. 11 m. 25 d.

Share capital:

200 000 PLN

Year	2018	2019	2020	2022	2023
Total assets	444 306,55	508 050,52	703 056,46	77 725,93	57 007,32
A. Fixed assets	15 551,53	26 359,80	22 859,88	13 086,14	13 086,14
B. Current assets	428 755,02	481 690,72	680 196,58	64 639,79	43 921,18
C. Share capital contributions (basic funds)	-	-	-	0,00	0,00
D. Own shares (stocks)	-	-	-	0,00	0,00
Total liabilities	444 306,55	508 050,52	703 056,46	77 725,93	57 007,32
A. Equity	4 687,75	154 760,75	228 156,77	-182,01	-23 098,80
B. Liabilities and provisions for liabilities	439 618,80	353 289,77	474 899,69	77 907,94	80 106,12
I. Long-term liabilities	-	-	-	-	-
II. Short-term liabilities	-	-	-	-	-

Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.